Home Featured Page 229

Featured

Latest

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple...

Psilera Initiates Landmark Preclinical Studies with New Psychedelic Derivatives aimed at...

Mindset Pharma Announces Publication of Three PCT Patent Applications for Its...

atai Life Sciences Reports Second Quarter 2021 Financial Results and Business...

Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of...

Why Does The Psychedelic Scene Ignore PCP? [Part 1]

PT257 – Robin Divine – Black People Trip

PTSF71 – Sexual Ethics in Psychedelics and Mistrust of Big Pharma

Modernization of Sacred Plant Medicine Traditions: At What Cost?

PT256 – Matthew D. Segall, Ph.D. – Consciousness, Capitalism, and Philosophy

1...228229230...299 Page 229 of 299

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club – Trip Sitting

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple...

Psilera Initiates Landmark Preclinical Studies with New Psychedelic Derivatives aimed at...

Mindset Pharma Announces Publication of Three PCT Patent Applications for Its...

atai Life Sciences Reports Second Quarter 2021 Financial Results and Business...

Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of...

Why Does The Psychedelic Scene Ignore PCP? [Part 1]

PT257 – Robin Divine – Black People Trip

PTSF71 – Sexual Ethics in Psychedelics and Mistrust of Big Pharma

Modernization of Sacred Plant Medicine Traditions: At What Cost?

PT256 – Matthew D. Segall, Ph.D. – Consciousness, Capitalism, and Philosophy

EDITOR PICKS

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY